company background image
HSIC logo

Henry Schein NasdaqGS:HSIC Stock Report

Last Price

US$65.61

Market Cap

US$7.9b

7D

2.0%

1Y

-7.2%

Updated

14 Apr, 2025

Data

Company Financials +

HSIC Stock Overview

Provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. More details

HSIC fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance1/6
Financial Health4/6
Dividends0/6

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

Henry Schein, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Henry Schein
Historical stock prices
Current Share PriceUS$65.61
52 Week HighUS$82.49
52 Week LowUS$60.56
Beta0.85
1 Month Change-7.04%
3 Month Change-7.94%
1 Year Change-7.24%
3 Year Change-27.21%
5 Year Change23.44%
Change since IPO1,053.58%

Recent News & Updates

We Think Henry Schein (NASDAQ:HSIC) Can Stay On Top Of Its Debt

Mar 28
We Think Henry Schein (NASDAQ:HSIC) Can Stay On Top Of Its Debt

Recent updates

We Think Henry Schein (NASDAQ:HSIC) Can Stay On Top Of Its Debt

Mar 28
We Think Henry Schein (NASDAQ:HSIC) Can Stay On Top Of Its Debt

Henry Schein, Inc. (NASDAQ:HSIC) Shares Could Be 32% Below Their Intrinsic Value Estimate

Mar 13
Henry Schein, Inc. (NASDAQ:HSIC) Shares Could Be 32% Below Their Intrinsic Value Estimate

Henry Schein Looks Bullish (Technical Analysis)

Mar 11

Henry Schein: An Industry Leader That Offers Some Upside From Here

Mar 04

Why Henry Schein, Inc. (NASDAQ:HSIC) Could Be Worth Watching

Feb 09
Why Henry Schein, Inc. (NASDAQ:HSIC) Could Be Worth Watching

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Jan 17
There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Henry Schein, Inc. (NASDAQ:HSIC) Not Lagging Market On Growth Or Pricing

Dec 31
Henry Schein, Inc. (NASDAQ:HSIC) Not Lagging Market On Growth Or Pricing

Henry Schein: The Kind Of Business I Like But No Margin Of Safety Now

Dec 10

Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?

Dec 01
Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?

Henry Schein: Another Day, Another Purchase

Nov 20

Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings

Nov 13
Henry Schein's (NASDAQ:HSIC) Conservative Accounting Might Explain Soft Earnings

Is Now An Opportune Moment To Examine Henry Schein, Inc. (NASDAQ:HSIC)?

Nov 04
Is Now An Opportune Moment To Examine Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc.'s (NASDAQ:HSIC) Popularity With Investors Is Clear

Sep 27
Henry Schein, Inc.'s (NASDAQ:HSIC) Popularity With Investors Is Clear
author-image

Critical Acquisitions And High-Growth Product Expansion Set To Transform Dental Giant

Aug 25 Expansion into high-growth products and strategic acquisitions aimed at increasing gross margins through improved integration and efficiency.

Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around

Aug 20
Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around

Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

Aug 02
Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings

Jun 27
Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

May 23

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

May 22
Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

May 02
Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Feb 28

Shareholder Returns

HSICUS HealthcareUS Market
7D2.0%8.3%6.8%
1Y-7.2%12.0%5.9%

Return vs Industry: HSIC underperformed the US Healthcare industry which returned 12.9% over the past year.

Return vs Market: HSIC underperformed the US Market which returned 4.8% over the past year.

Price Volatility

Is HSIC's price volatile compared to industry and market?
HSIC volatility
HSIC Average Weekly Movement4.4%
Healthcare Industry Average Movement7.4%
Market Average Movement7.7%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market4.1%

Stable Share Price: HSIC has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: HSIC's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
193225,000Stan Bergmanwww.henryschein.com

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins.

Henry Schein, Inc. Fundamentals Summary

How do Henry Schein's earnings and revenue compare to its market cap?
HSIC fundamental statistics
Market capUS$7.90b
Earnings (TTM)US$390.00m
Revenue (TTM)US$12.67b

20.6x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HSIC income statement (TTM)
RevenueUS$12.67b
Cost of RevenueUS$8.66b
Gross ProfitUS$4.02b
Other ExpensesUS$3.63b
EarningsUS$390.00m

Last Reported Earnings

Dec 28, 2024

Next Earnings Date

May 05, 2025

Earnings per share (EPS)3.18
Gross Margin31.69%
Net Profit Margin3.08%
Debt/Equity Ratio52.4%

How did HSIC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/14 10:18
End of Day Share Price 2025/04/14 00:00
Earnings2024/12/28
Annual Earnings2024/12/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Henry Schein, Inc. is covered by 38 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Ishan MajumdarBaptista Research
Lawrence MarshBarclays